Document Detail

Anti-Metastatic and Anti-Angiogenic Properties Of Potential New Anti-Cancer Drugs Based on Metal Complexes Of Selenosemicarbazones.
MedLine Citation:
PMID:  22583413     Owner:  NLM     Status:  Publisher    
Our previous studies showed that zinc (II), cadmium (II) and nickel (II) complexes with 2-formylpyridine selenosemicarbazone induce apoptosis in cancer cells via activation of mitochondrial pathway. Herein, we reported their antimetastatic properties. Nickel (II), and zinc (II) complexes exhibited the strongest inhibitory potential towards MMP-2/9, while all investigated compounds significantly decreased proteolytic activity of MMP-2/9 in human breast cancer MDA-MB-361 cells. As shown by in vitro transmembrane assays, nickel (II) complex was the most effective in inhibiting invasion of MDA-MB-361 cells, while the cadmium (II) complex was the most active in inhibiting HeLa cells invasion. In malignant cells, the complexes inhibited intracellular accumulation of reactive oxygen species, known for its pro-angiogenic properties via VEGF signaling, but no reduction in total cellular amount of VEGF was found. Furthermore, tubulogenesis test showed anti-angiogenic effect of the complexes in treated endothelial cells. Data indicate multiple mechanisms of the complexes' anti-angiogenic properties. In addition, they could modulate metastatic phenotype of tumor cells. Nickel (II) complex with 2-formylpyridine selenosemicarbazone revealed to be the most potent.
Manja Zec; Tatjana Srdic-Rajic; Aleksandra Konic-Ristics; Tamara Todorovic; Katarina Andjelkovic; Ivana Filipovic-Ljeskovic; Sinisa Radulovic
Related Documents :
1899143 - Cell-autonomous role of notch, an epidermal growth factor homologue, in sensory organ d...
8646773 - Drosophila photoreceptor axon guidance and targeting requires the dreadlocks sh2/sh3 ad...
11496183 - Influence of different biodegradable carriers on the in vivo behavior of human adipose ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-2
Journal Detail:
Title:  Anti-cancer agents in medicinal chemistry     Volume:  -     ISSN:  1875-5992     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101265649     Medline TA:  Anticancer Agents Med Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
S. Radulovic MD, Ph.D, National Cancer Research Center, Department of Experimental Pharmacology, Pasterova 14, 11 000 Belgrade, Serbia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Calculation of Molecular Features with Apparent Impact on Both Activity Of Mutagens And Activity Of ...
Next Document:  The Role of Peroxisome Proliferator-Activated Receptor-? in Breast Cancer.